175 related articles for article (PubMed ID: 22713596)
1. Immune response modifiers in the treatment of asthma: A PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology.
Ballow M; Akdis CA; Casale TB; Wardlaw AJ; Wenzel SE; Ballas Z; Lötvall J
J Allergy Clin Immunol; 2012 Aug; 130(2):311-24. PubMed ID: 22713596
[No Abstract] [Full Text] [Related]
2. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report.
Burks AW; Calderon MA; Casale T; Cox L; Demoly P; Jutel M; Nelson H; Akdis CA
J Allergy Clin Immunol; 2013 May; 131(5):1288-96.e3. PubMed ID: 23498595
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report.
Akdis CA; Akdis M; Bieber T; Bindslev-Jensen C; Boguniewicz M; Eigenmann P; Hamid Q; Kapp A; Leung DY; Lipozencic J; Luger TA; Muraro A; Novak N; Platts-Mills TA; Rosenwasser L; Scheynius A; Simons FE; Spergel J; Turjanmaa K; Wahn U; Weidinger S; Werfel T; Zuberbier T;
J Allergy Clin Immunol; 2006 Jul; 118(1):152-69. PubMed ID: 16815151
[TBL] [Abstract][Full Text] [Related]
4. Allergen immunotherapy: a new semantic framework from the European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report.
Calderón MA; Casale T; Cox L; Akdis CA; Burks AW; Nelson HS; Jutel M; Demoly P
Allergy; 2013 Jul; 68(7):825-8. PubMed ID: 24010140
[No Abstract] [Full Text] [Related]
5. New perspectives on mechanisms underlying chronic allergic inflammation and asthma in 2007.
Broide D
J Allergy Clin Immunol; 2008 Sep; 122(3):475-80. PubMed ID: 18694589
[TBL] [Abstract][Full Text] [Related]
6. Immune modulation for treatment of allergic disease.
Nguyen TH; Casale TB
Immunol Rev; 2011 Jul; 242(1):258-71. PubMed ID: 21682751
[TBL] [Abstract][Full Text] [Related]
7. Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology.
Muraro A; Lemanske RF; Hellings PW; Akdis CA; Bieber T; Casale TB; Jutel M; Ong PY; Poulsen LK; Schmid-Grendelmeier P; Simon HU; Seys SF; Agache I
J Allergy Clin Immunol; 2016 May; 137(5):1347-58. PubMed ID: 27155030
[TBL] [Abstract][Full Text] [Related]
8. Concerns about intranasal corticosteroids for over-the-counter use: position statement of the Joint Task Force for the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology.
Bielory L; Blaiss M; Fineman SM; Ledford DK; Lieberman P; Simons FE; Skoner DP; Storms WW; ;
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):514-25. PubMed ID: 16680921
[TBL] [Abstract][Full Text] [Related]
9. Asthma in Childhood: Expression, Exacerbation, and Progression.
Lemanske RF
J Allergy Clin Immunol Pract; 2016; 4(1):36-7. PubMed ID: 26772925
[No Abstract] [Full Text] [Related]
10. Strategies for targeting T-cells in allergic diseases and asthma.
Heijink IH; Van Oosterhout AJ
Pharmacol Ther; 2006 Nov; 112(2):489-500. PubMed ID: 16814862
[TBL] [Abstract][Full Text] [Related]
11. Changes of immunomodulatory cytokines associated with omalizumab therapy for severe persistent asthma.
Shimizu Y; Dobashi K; Fueki N; Fueki M; Okada T; Tomioka S; Makino S; Mori M
J Biol Regul Homeost Agents; 2011; 25(2):177-86. PubMed ID: 21880206
[TBL] [Abstract][Full Text] [Related]
12. Precision medicine in allergic disease-food allergy, drug allergy, and anaphylaxis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology.
Muraro A; Lemanske RF; Castells M; Torres MJ; Khan D; Simon HU; Bindslev-Jensen C; Burks W; Poulsen LK; Sampson HA; Worm M; Nadeau KC
Allergy; 2017 Jul; 72(7):1006-1021. PubMed ID: 28122115
[TBL] [Abstract][Full Text] [Related]
13. The microbiome in allergic disease: Current understanding and future opportunities-2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology.
Huang YJ; Marsland BJ; Bunyavanich S; O'Mahony L; Leung DY; Muraro A; Fleisher TA
J Allergy Clin Immunol; 2017 Apr; 139(4):1099-1110. PubMed ID: 28257972
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report.
Akdis CA; Akdis M; Bieber T; Bindslev-Jensen C; Boguniewicz M; Eigenmann P; Hamid Q; Kapp A; Leung DY; Lipozencic J; Luger TA; Muraro A; Novak N; Platts-Mills TA; Rosenwasser L; Scheynius A; Simons FE; Spergel J; Turjanmaa K; Wahn U; Weidinger S; Werfel T; Zuberbier T; ;
Allergy; 2006 Aug; 61(8):969-87. PubMed ID: 16867052
[TBL] [Abstract][Full Text] [Related]
15. [Theory and practice of specific desensitization in allergic diseases].
Ferstl A
Wien Z Inn Med; 1966 Oct; 47(10):413-20. PubMed ID: 4187168
[No Abstract] [Full Text] [Related]
16. Th2 cells as targets for therapeutic intervention in allergic bronchial asthma.
Wegmann M
Expert Rev Mol Diagn; 2009 Jan; 9(1):85-100. PubMed ID: 19099351
[TBL] [Abstract][Full Text] [Related]
17. Reassessing the Th2 cytokine basis of asthma.
O'Byrne PM; Inman MD; Adelroth E
Trends Pharmacol Sci; 2004 May; 25(5):244-8. PubMed ID: 15120489
[TBL] [Abstract][Full Text] [Related]
18. IL-13 and the IL-13 receptor as therapeutic targets for asthma and allergic disease.
Mitchell J; Dimov V; Townley RG
Curr Opin Investig Drugs; 2010 May; 11(5):527-34. PubMed ID: 20419598
[TBL] [Abstract][Full Text] [Related]
19. [Biological engineering for new asthma therapy].
Van Hage M; Grönlund H; Gafvelin G
Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1942-5. PubMed ID: 18681377
[No Abstract] [Full Text] [Related]
20. Home therapy with subcutaneous anti-immunoglobulin-E antibody omalizumab in 25 patients with immunoglobulin-E-mediated (allergic) asthma.
Liebhaber M; Dyer Z
J Asthma; 2007 Apr; 44(3):195-6. PubMed ID: 17454337
[No Abstract] [Full Text] [Related]
[Next] [New Search]
